Original Research
Published on 21 Sep 2021
Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs
in Pharmacogenetics and Pharmacogenomics
- 3,870 views
- 3 citations
Original Research
Published on 21 Sep 2021
in Pharmacogenetics and Pharmacogenomics
Perspective
Published on 17 Sep 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 17 Sep 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 16 Sep 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 14 Sep 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 13 Sep 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 02 Sep 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 31 Aug 2021
in Pharmacogenetics and Pharmacogenomics
Review
Published on 30 Aug 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 27 Aug 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 26 Aug 2021
in Pharmacogenetics and Pharmacogenomics
Review
Published on 25 Aug 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 18 Aug 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 13 Aug 2021
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 26 Jul 2021
in Pharmacogenetics and Pharmacogenomics
Brief Research Report
Published on 23 Jul 2021
in Pharmacogenetics and Pharmacogenomics